Page last updated: 2024-11-05

2,2',2''-trichlorotriethylamine and Granuloma, Hodgkin

2,2',2''-trichlorotriethylamine has been researched along with Granuloma, Hodgkin in 4 studies

2,2',2''-trichlorotriethylamine: RN given refers to parent cpd; structure

Research Excerpts

ExcerptRelevanceReference
"Fifty-three patients with advanced Hodgkin's disease, most of them previously treated, received 8 to 16 courses of modified MOPP regimens (nitrogen mustard replaced by trichlormethine in arm A, with addition of vinblastine to the 4-drug regimen in arm B, and alternation of three drugs--trichlormethine, vincristine, and prednisone--with probably non-cross resistant two drugs--vinblastine and procarbazine in arm C)."1.28Treatment of advanced Hodgkin's disease with modified MOPP regimens. A long-term observation. ( Bohunický, L; Cerný, V; Gyárfás, J; Koza, I; Mardiak, J; Svancárová, L, 1989)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
TEWES, H1
Goodman, LS1
Wintrobe, MM1
Dameshek, W1
Goodman, MJ1
Gilman, A1
McLennan, MT1
Klener, P1
Donner, L1
Koza, I1
Bohunický, L1
Svancárová, L1
Mardiak, J1
Gyárfás, J1
Cerný, V1

Other Studies

4 other studies available for 2,2',2''-trichlorotriethylamine and Granuloma, Hodgkin

ArticleYear
[Roentgen resistant lymphogranulomatosis treated with trichlorotriethylamine hydrochloride, with special reference to following modifications in the hemopoietic system].
    Medizinische Monatsschrift, 1950, Volume: 4, Issue:7

    Topics: Hematopoietic System; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Sarcoidosis

1950
Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.
    JAMA, 1984, May-04, Volume: 251, Issue:17

    Topics: History, 20th Century; Hodgkin Disease; Humans; Leukemia; Lymphoma, Non-Hodgkin; Mechlorethamine; Ne

1984
Trichlortriethylamine (TS-160 Spofa) in combination chemotherapy of malignant lymphomas.
    Neoplasma, 1975, Volume: 22, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymp

1975
Treatment of advanced Hodgkin's disease with modified MOPP regimens. A long-term observation.
    Neoplasma, 1989, Volume: 36, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Hu

1989